Immunotoxicity of silver nanoparticles in an intravenous 28-day repeated-dose toxicity study in rats

BACKGROUND: Nanosilver is used in a variety of medical and consumer products because of its antibacterial activity. This wide application results in an increased human exposure. Knowledge on the systemic toxicity of nanosilver is, however, relatively scarce. In a previous study, the systemic toxicit...

Descripción completa

Detalles Bibliográficos
Autores principales: Vandebriel, Rob J, Tonk, Elisa CM, de la Fonteyne-Blankestijn, Liset J, Gremmer, Eric R, Verharen, Henny W, van der Ven, Leo T, van Loveren, Henk, de Jong, Wim H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052812/
https://www.ncbi.nlm.nih.gov/pubmed/24885556
http://dx.doi.org/10.1186/1743-8977-11-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4052812/
https://www.ncbi.nlm.nih.gov/pubmed/24885556
http://dx.doi.org/10.1186/1743-8977-11-21

Ejemplares similares